Table 6

Health related quality of evaluated life (HRQoL) by Short-Form 36 (SF-36) at baseline and follow-up in patients grouped according to their answer to the statement at follow-up that 'The expectations I had regarding my treatment have been met'

Completely disagree
Baseline n=48
Follow-up n=44 		Agree partially
Baseline n=79
Follow-up n=76 		Agree almost entirely
Baseline n=83
Follow-up n=82 		Agree entirely
Baseline n=272
Follow-up n=265 		Correlation of baseline values between the four alternatives from completely disagree to agree entirely† Correlation of changes from baseline to follow-up between the four alternatives from completely disagree to agree entirely #
Mean (SD)Mean (SD)Mean (SD)Mean (SD)p valuers
p value
PFBaseline
Follow-up
Change		50.1 (25.7)
51.4 (25.5)
0.000 (10.7)		51.7 (21.4)
56.2 (23.7)
3.73 (18.2)		63.0 (23.6)
71.5 (24.1)
8.75 (19.8)***		65.2 (20.9)
77.0 (19.9)
11.8 (19.2)***		rs=0.24
<0.0001
rs=0.36 p<0.0001		rs=0.22
<0.0001
RPBaseline
Follow-up
Change		27.3 (35.7)
26.7 (37.9)
0.610 (32.4)		24.7 (35.2)
28.2 (36.3)
4.51 (40.8)		43.4 (40.6)
55.9 (40.4)
11.8 (37.1)**		42.8 (41.1)
64.2 (40.7)
21.1 (47.3)***		rs=0.15
0.001
rs=0.34 p<0.0001		rs=0.18
0.0001
BPBaseline
Follow-up
Change		45.3 (25.1)
47.6 (27.4)
0.825 (20.6)		46.5 (19.9)
55.7 (23.3)
9.21 (26.2)**		60.1 (25.0)
68.4 (25.9)
8.49 (23.3)**		58.7 (25.1)
76.1 (26.2)
16.9 (28.0)***		rs=0.18
0.0001
rs=0.36 p<0.0001		rs=0.19
<0.0001
GHBaseline
Follow-up
Change		49.1 (20.0)
43.8 (17.5)
−4.30 (13.6)		49.5 (18.4)
46.0 (19.8)
−3.65 (19.2)		57.3 (17.5)
57.9 (20.5)
0.416 (15.9)		59.0 (20.8)
68.0 (22.0)
8.70 (20.1)***		rs=0.20
<0.0001
rs=0.42 p<0.0001		rs=0.28
<0.0001
VTBaseline
Follow-up
Change		37.7 (23.2)
41.6 (21.3)
1.46 (20.3)		41.2 (18.1)
43.7 (19.3)
2.91 (19.8)		50.8 (22.2)
56.5 (21.5)
5.78 (17.4)**		50.5 (23.7)
63.5 (24.1)
12.8 (23.9)***		rs=0.17
0.0003
rs=0.36 p<0.0001		rs=0.21
<0.0001
SFBaseline
Follow-up
Change		65.0 (29.7)
72.7 (26.3)
5.95 (22.5)		64.7 (26.2_)
67.9 (25.3)
1.86 (26.1)		72.5 (23.3)
77.0 (20.8)
4.81 (20.1)		76.5 (23.2)
85.3 (21.7)
8.78 (24.4)***		rs=0.18
0.0001
rs=0.30 p<0.0001		rs=0.10
0.041
REBaseline
Follow-up
Change		56.5 (45.0)
53.6 (45.8)
−2.96 (44.9)		54.7 (42.1)
47.2 (43.7)
−4.84 (53.8)		64.1 (43.9)
68.3 (38.8)
5.64 (42.7)		59.4 (41.3)
75.2 (37.8)
16.1 (47.2)***		rs=0.02
0.70
rs=0.25 p<0.0001		rs=0.18
0.0001
MHBaseline
Follow-up
Change		64.2 (23.7)
69.9 (22.6)
2.44 (16.8)		65.2 (19.6)
66.4 (19.6)
1.18 (17.0)		70.1 (18.0)
71.5 (18.8)
1.28 (15.8)		71.8 (19.4)
80.2 (18.7)
8.19 (18.3)***		rs=0.13
0.004
rs=0.29 p<0.0001		rs=0.19
<0.0001

  • For comparison between baseline and follow-up Wilcoxon signed-ranks test were used and significance set at *p<0.05, **p<0.01 and ***p<0.001.

  • † For comparison between the four alternatives rs= Spearmen’s rank correlation test were used for continuous variables.

  • B, baseline; BP, bodily pain; FU, follow-up; GH, general health; MH, mental health; PF, physical function; RE, role emotional; RP, role physical; SF, social function.